Follow


Submissions from 2017

PDF

Reversion of Epithelial-Mesenchymal Transition by a Novel Agent DZ-50 via IGF Binding Protein-3 in Prostate Cancer Cells, Zheng Cao, Shahriar Koochekpour, Stephen E. Strup, and Natasha Kyprianou

PDF

Primary Upper Urinary Tract Small Cell Carcinoma: A Case Series and Literature Review, Patrick J. Hensley, Amul A. Bhalodi, and Shubham Gupta

Submissions from 2016

PDF

Salvage Brachytherapy for Biochemically Recurrent Prostate Cancer Following Primary Brachytherapy, John M. Lacy, William A. Wilson, Raevti Bole, Li Chen, Ali S. Meigooni, Randall G. Rowland, and William H. St. Clair

Submissions from 2015

PDF

An Ex Vivo Approach to Complex Renal Artery Aneurysm Repair, Noah T. Scherrer, Roberto Gedaly, Ramakrishna Venkatesh, Michael A. Winkler, and Eleftherios S. Xenos

PDF

CD151-α3β1 Integrin Complexes are Prognostic Markers of Glioblastoma and Cooperate with EGFR to Drive Tumor Cell Motility and Invasion, Pengcheng Zhou, Sonia Erfani, Zeyi Liu, Changhe Jia, Yecang Chen, Bingwei Xu, Xinyu Deng, Jose E. Alfáro, Li Chen, Dana L. Napier, Michael Lu, Jian-An Huang, Chunming Liu, Olivier Thibault, Rosalind Segal, Binhua P. Zhou, Natasha Kyprianou, Craig Horbinski, and Xiuwei H. Yang

Submissions from 2014

PDF

A Tale of Two Trials: The Impact of 5α-Reductase Inhibition on Prostate Cancer (Review), John M. Lacy and Natasha Kyprianou

PDF

The Promise of Novel Molecular Markers in Bladder Cancer, Jahan Miremami and Natasha Kyprianou